|
English
|
正體中文
|
简体中文
|
总笔数 :0
|
|
造访人次 :
51190007
在线人数 :
760
教育部委托研究计画 计画执行:国立台湾大学图书馆
|
|
|
"mo l r"的相关文件
显示项目 56-65 / 70 (共7页)
<< < 1 2 3 4 5 6 7 > >>
每页显示[10|25|50]项目
| 臺大學術典藏 |
2020-11-27T03:28:38Z |
Association Between Serum Level of Hepatitis B Surface Antigen at End of Entecavir Therapy and Risk of Relapse in E Antigen–Negative Patients
|
Hsu Y.-C.; Mo L.-R.; Chang C.-Y.; Wu M.-S.; Kao J.-H.; Wang W.-L.; Yang T.-H.; Wang C.-S.; Chiang M.-F.; CHIEH-CHANG CHEN; Fang Y.-J.; Hung H.-W.; Wu C.-Y.; Lin J.-T. |
| 臺大學術典藏 |
2020-11-27T03:28:37Z |
Serum viral load at the virological relapse predicts subsequent clinical flares in chronic hepatitis B patients off entecavir therapy
|
Hsu Y.-C.; Mo L.-R.; Chang C.-Y.; Wu M.-S.; Yang T.-H.; Kao J.-H.; CHIEH-CHANG CHEN; Tseng C.-H.; Tai C.-M.; Lin C.-W.; Wu C.-Y.; Lin J.-T. |
| 臺大學術典藏 |
2020-11-27T03:28:35Z |
Combining hepatitis B core-related and surface antigens at end of nucleos(t)ide analogue treatment to predict off-therapy relapse risk
|
Hsu Y.-C.; Nguyen M.H.; Mo L.-R.; Wu M.-S.; Yang T.-H.; CHIEH-CHANG CHEN; Tseng C.-H.; Tai C.-M.; Wu C.-Y.; Lin J.-T.; Tanaka Y.; Chang C.-Y. |
| 臺大學術典藏 |
2020-11-19T03:19:31Z |
Heavy alcohol consumption increases the incidence of hepatocellular carcinoma in hepatitis B virus-related cirrhosis
|
Lin C.-W.; Lin C.-C.; Mo L.-R.; Chang C.-Y.; Perng D.-S.; Hsu C.-C.; Lo G.-H.; Chen Y.-S.; Yen Y.-C.; Hu J.-T.; Yu M.-L.; PO-HUANG LEE; Lin J.-T.; Yang S.-S. |
| 臺大學術典藏 |
2020-11-02T02:04:26Z |
Association Between Serum Level of Hepatitis B Surface Antigen at End of Entecavir Therapy and Risk of Relapse in E Antigen�VNegative Patients
|
Lin J.-T.; Wu C.-Y.; Hung H.-W.; Fang Y.-J.; Chen C.-C.; Chiang M.-F.; Wang C.-S.; Yang T.-H.; Wang W.-L.; Kao J.-H.; MING-SHIANG WU; Chang C.-Y.; Hsu Y.-C.; Mo L.-R. |
| 臺大學術典藏 |
2020-11-02T02:04:21Z |
Serum viral load at the virological relapse predicts subsequent clinical flares in chronic hepatitis B patients off entecavir therapy
|
Lin J.-T.; Wu C.-Y.; Lin C.-W.; Tai C.-M.; Chen C.-C.; Tseng C.-H.; Kao J.-H.; Yang T.-H.; MING-SHIANG WU; Chang C.-Y.; Mo L.-R.; Hsu Y.-C. |
| 臺大學術典藏 |
2020-11-02T02:04:10Z |
Combining hepatitis B core-related and surface antigens at end of nucleos(t)ide analogue treatment to predict off-therapy relapse risk
|
Chang C.-Y.; Lin J.-T.; Tanaka Y.; Wu C.-Y.; Tseng C.-H.; Tai C.-M.; Hsu Y.-C.; Nguyen M.H.; Mo L.-R.; MING-SHIANG WU; Yang T.-H.; Chen C.-C. |
| 臺大學術典藏 |
2020-08-11T08:36:45Z |
Doxorubicin-modified magnetic nanoparticles as a drug delivery system for magnetic resonance imaging-monitoring magnet-enhancing tumor chemotherapy
|
PO-CHIN LIANG; Chen Y.-C.; Chiang C.-F.; Mo L.-R.; Wei S.-Y.; Hsieh W.-Y.; Lin W.-L. |
| 臺大學術典藏 |
2020-02-26T09:00:49Z |
Doxorubicin-modified magnetic nanoparticles as a drug delivery system for magnetic resonance imaging-monitoring magnet-enhancing tumor chemotherapy
|
Liang P.-C.; Chen Y.-C.; Chiang C.-F.; Mo L.-R.; Wei S.-Y.; Hsieh W.-Y.; Win-Li Lin |
| 臺大學術典藏 |
2018-09-10T18:03:52Z |
Time-varying serum gradient of hepatitis B surface antigen predicts risk of relapses after off-NA therapy
|
Chien, N.-H.;Huang, Y.-T.;Wu, C.-Y.;Chang, C.-Y.;Wu, M.-S.;Kao, J.-H.;Mo, L.-R.;Tai, C.-M.;Lin, C.-W.;Yang, T.-H.;Lin, J.-T.;Hsu, Y.-C.; MING-SHIANG WU; JIA-HORNG KAO |
显示项目 56-65 / 70 (共7页)
<< < 1 2 3 4 5 6 7 > >>
每页显示[10|25|50]项目
|
